Literature DB >> 8339506

Biochemical changes associated with the symptomatic human intervertebral disk.

T Kitano1, J E Zerwekh, Y Usui, M L Edwards, P L Flicker, V Mooney.   

Abstract

Significant changes in disk biochemistry were evident in the nuclei pulposi of 25 symptomatic disks that demonstrated abnormal diskography. Compared with the results from ten normal disk from young subjects (mean age, ten years) and from ten asymptomatic disks from adult patients (mean age, 33 years), the symptomatic disks demonstrated significantly greater collagen content than the young and asymptomatic adult subjects, respectively. Significantly fewer total glycosaminoglycans (GAGs) and significantly less water content were also evident for the diseased disks. The mean pH of the nucleus pulposus from 23 patients was also significantly reduced for the symptomatic disks as compared with the mean pH measured for four asymptomatic adult subjects. Although significantly fewer total GAGs were observed for the symptomatic disks, there were no significant differences in the percent composition of hyaluronic acid (HA), chondroitin sulfate (CS), or keratan sulfate (KS) among the normal and symptomatic disks. Significant changes in disk biochemistry are associated with the symptomatic disk, and these changes could contribute to the development of the painful disk syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8339506

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  26 in total

1.  Investigation of solute concentrations in a 3D model of intervertebral disc.

Authors:  D Mokhbi Soukane; A Shirazi-Adl; J P G Urban
Journal:  Eur Spine J       Date:  2008-11-18       Impact factor: 3.134

2.  Effects of mechanical compression on metabolism and distribution of oxygen and lactate in intervertebral disc.

Authors:  Chun-Yuh Huang; Wei Yong Gu
Journal:  J Biomech       Date:  2008       Impact factor: 2.712

3.  Optimization of protein crosslinking formulations for the treatment of degenerative disc disease.

Authors:  Paul Slusarewicz; Keng Zhu; Bryan Kirking; Justin Toungate; Tom Hedman
Journal:  Spine (Phila Pa 1976)       Date:  2011-01-01       Impact factor: 3.468

Review 4.  Disc cell therapies: critical issues.

Authors:  Marta Tibiletti; Nevenka Kregar Velikonja; Jill P G Urban; Jeremy C T Fairbank
Journal:  Eur Spine J       Date:  2014-02-08       Impact factor: 3.134

5.  Multiplex Epigenome Editing of Dorsal Root Ganglion Neuron Receptors Abolishes Redundant Interleukin 6, Tumor Necrosis Factor Alpha, and Interleukin 1β Signaling by the Degenerative Intervertebral Disc.

Authors:  Joshua D Stover; Niloofar Farhang; Brandon Lawrence; Robby D Bowles
Journal:  Hum Gene Ther       Date:  2019-06-11       Impact factor: 5.695

6.  Behavior of mesenchymal stem cells in the chemical microenvironment of the intervertebral disc.

Authors:  Karin Wuertz; Karolyn Godburn; Cornelia Neidlinger-Wilke; Jocelyn Urban; James C Iatridis
Journal:  Spine (Phila Pa 1976)       Date:  2008-08-01       Impact factor: 3.468

7.  The effect of extracellular pH on matrix turnover by cells of the bovine nucleus pulposus.

Authors:  Sajjad Razaq; Robert J Wilkins; Jill P G Urban
Journal:  Eur Spine J       Date:  2003-07-16       Impact factor: 3.134

8.  MSC response to pH levels found in degenerating intervertebral discs.

Authors:  Karin Wuertz; Karolyn Godburn; James C Iatridis
Journal:  Biochem Biophys Res Commun       Date:  2009-01-06       Impact factor: 3.575

9.  Isolated Lumbar Extension Resistance Training Improves Strength, Pain, and Disability, but Not Spinal Height or Shrinkage ("Creep") in Participants with Chronic Low Back Pain.

Authors:  James Steele; Stewart Bruce-Low; Dave Smith; David Jessop; Neil Osborne
Journal:  Cartilage       Date:  2017-02-01       Impact factor: 4.634

10.  An injectable nucleus replacement as an adjunct to microdiscectomy: 2 year follow-up in a pilot clinical study.

Authors:  Ulrich Berlemann; Othmar Schwarzenbach
Journal:  Eur Spine J       Date:  2009-08-18       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.